Somatic mutations in renal cell carcinomas from Chinese patients revealed by whole exome sequencing

Table 1 clinical and pathological information of RCC patients

Sample ID	Gender	Age at Diagnosis	Surgical Approach	Histological Subtype	Laterality	Tumor Grade	TNM Stage	Tumor Stage
1	M	44	LSRN	ccRCC	Left	G3	T3aN0M0	III
3	M	33	LSPN	ccRCC	Left	G1	T1aN0M0	I
4	M	60	LSRN	ccRCC	Left	G2	T1aN0M0	I
5	F	52	LSPN	ccRCC	Left	G1	T1aN0M0	I
6	M	59	LSPN	ccRCC	Left	G1	T1aN0M0	I
7	F	59	LSRN	ChRCC	Right	NA	T1bN0M0	I
8	F	70	LSPN	ccRCC	Right	G1	T1aN0M0	I
9	F	58	LSRN	ccRCC	Right	G2	T3aN0M0	III
10	M	49	LSRN	ccRCC	Right	G2	T2aN0M0	II
11	M	70	LSRN	ccRCC	Right	G1	T1bN0M0	I
12	M	76	LSRN	ccRCC	Right	G3	T3bN0M0	III
13	M	46	LSPN	ccRCC	Left	G3	T1aN0M0	I
14	M	63	LSRN	ccRCC	Right	G2	T1bN0M0	I
15	M	52	LSRN	ccRCC	Left	G1	T1bN0M0	I
25	F	43	ORN	ChRCC	Left	NA	T2bN0M0	II
36	M	38	LSRN	ccRCC	Left	G3	T1aN0M0	I
38	M	60	LSRN	ccRCC	Left	G1	T1bN0M0	I
39	F	24	LSRN	ChRCC	Right	NA	T1bN0M0	I
78	M	54	LSRN	ChRCC	Left	NA	T3aN0M0	III
82	F	76	LSPN	PRCC (II)	Right	G3	T1aN0M0	I
98	F	63	LSPN	ChRCC	Left	NA	T1aN0M0	I
114	M	65	LSRN	ChRCC	Right	NA	T1bN0M0	I
129	M	52	LSRN	PRCC (II)	Right	G2	T3aN0M0	III
130	F	78	LSRN	PRCC (II)	Right	G2	T1bN0M0	I
131	M	72	LSPN	PRCC (II)	Right	G2	T1aN0M0	I
137	M	38	LSPN	PRCC (I)	Right	G2	T1aN0M0	I

M, male; F, female; LSRN, laparoscopic radical nephrectomy; LSPN, laparoscopic partial nephrectomy; ORN, open radical nephrectomy; NA, not available

ISSN: 1475-2867